NeoGenomics NEO Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 43.2%-0.7pp | 43.9%+2.6pp | 41.3%+4.5pp | 36.9%-1.8pp | |
| Operating margin | -15.9%-2.0pp | -13.9%+4.3pp | -18.2%+12.7pp | -30.9%-6.4pp | |
| Net margin | -14.9%-2.9pp | -11.9%+3.0pp | -14.9%+13.4pp | -28.3%-26.6pp | |
| EBITDA margin | -6.6%-3.6pp | -3%+3.0pp | -5.9%+11.4pp | -17.3%-3.8pp | |
| Returns | |||||
| Return on equity | -12.4%-3.9pp | -8.5%+0.5pp | -9.1%+4.6pp | -13.7%-12.8pp | |
| Return on assets | -7.2%-2.5pp | -4.7%+0.4pp | -5.1%+2.8pp | -8%-7.4pp | |
| Return on invested capital | -15%-2.5pp | -12.5%+2.0pp | -14.5%+4.2pp | -18.7%-1.6pp | |
| Efficiency | |||||
| Asset turnover | 0.5×+0.1× | 0.4×+0.1× | 0.3×+0.1× | 0.3×-0.1× | |
| Inventory turnover | 14.9×+0.4× | 14.6×+0.2× | 14.3×+0.8× | 13.5×+2.3× | |
| Liquidity | |||||
| Current ratio | 4.3×+2.3× | 2×-4.2× | 6.2×-0.5× | 6.7×-1.1× | |
| Quick ratio | 3.9×+2.0× | 1.9×-4.1× | 5.9×-0.5× | 6.5×-1.1× | |
| Cash ratio | 1.8×+0.6× | 1.2×-2.3× | 3.6×+0.6× | 2.9×-0.7× | |
| Leverage | |||||
| Debt-to-equity | 0.1×-0.2× | 0.3×+0.2× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×-0.1× | 0.2×+0.1× | 0×0.0× | 0×0.0× | |
| Interest coverage | -30.9×-17.0× | -13.9×+1.7× | -15.6×+5.2× | -20.8×-6.3× | |
| Per Share | |||||
| Book value per share | $6.53-8.3% | $7.12-5.0% | $7.50-6.6% | $8.03-13.0% | |
| Valuation | |||||
| Market capitalization | $1.68B+86.5% | $2.12B+3.8% | $2.04B+76.8% | $1.15B-72.7% | |
| Enterprise value | $1.6B+159% | $2.01B+13.8% | $1.77B+83.3% | $964.78M-75.7% | |
| Price / sales | 2.3×+0.9× | 3.2×-0.2× | 3.4×+1.2× | 2.3×-6.4× | |
| Price / book | 2×+1.0× | 2.3×+0.2× | 2.2×+1.0× | 1.2×-2.6× | |
| EV / sales | 2.1×+1.2× | 3×+0.1× | 3×+1.1× | 1.9×-6.3× | |
| Earnings yield | -5.9%+2.7pp | -3.7%+0.6pp | -4.3%+8.2pp | -12.5%-12.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are NeoGenomics's profit margins?
- NeoGenomics (NEO) runs a 43.2% gross margin and a -14.2% operating margin, with a -13.3% net margin.
- Where do NeoGenomics's ratios come from?
- Every ratio is computed from NeoGenomics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
